common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

CD71 in Dried Blood Spots in Healthy Males

Understand the effect of recombinant EPO (rEPO) boosting and microdosing on the hematological module of the Athlete Biological Passport (ABP) - Measure the change in CD71 longitudinally in subjects from both cohorts - Assess whether rEPO administration can be detected in a dried blood spot (DBS) using recent advances in analytical methodologies - Compare windows of rEPO detection using both Athlete Biological Passport models and direct detection using analytical methods in urine, blood, and DBS

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - EPOGEN® (epoetin alfa)

Active drug

Normal Saline

Placebo

participant.views.study.view.additional

participant.views.study.view.scientific-title

Evaluation of CD71 Expression in a Dried Blood Spot Following rEPO Administration

common.study.values.clinical-trial-id

NCT04073849

participant.views.study.view.id

e0RzKb